Patent · US Active

BCMA-targeting antibody and use thereof

US11525006B2 · kind B2 · utility

1Cited by

3References

24Claims

0Family size

Assignee

CRAGE MEDICAL CO., LIMITED · CN

Inventors

Peng Wang · Carlsbad, US
Huamao WANG · Shanghai, CN
Hua Jiang · Shanghai, CN

Key dates

Filing date	Jan 23, 2018
Grant date	Dec 13, 2022
Priority date	—
Expiry date	May 27, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/15043
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided in the present invention are a specific antibody of BCMA and a BCMA-targeting immune effector cell, and also provided are a chimeric antigen receptor-modified T cell prepared using the antibody and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.